ASX:PMEHealthcare Services
Assessing Pro Medicus’s Valuation After Director Buying And Upcoming Dividend Attract Attention
Pro Medicus (ASX:PME) is back in focus after co founders and directors bought A$3.4 million of shares on market, with investors also eyeing the upcoming interim dividend payment on March 20.
See our latest analysis for Pro Medicus.
Despite the director buying and upcoming dividend, Pro Medicus shares have experienced a sharp reset, with a 30 day share price return of a 34.8% decline and a 1 year total shareholder return of a 55.6% decline, contrasting with still positive 3 and 5 year total...